n/a
Article Publish Status: FREE
Abstract Title:

Ascorbic acid: a promising agent in chronic kidney disease?

Abstract Source:

Clin Kidney J. 2018 Aug ;11(4):530-531. Epub 2018 Jun 26. PMID: 30094017

Abstract Author(s):

Salih Karahan, Baris Afsar, Mehmet Kanbay

Article Affiliation:

Salih Karahan

Abstract:

Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problem in CKD patients, and both have an important role in the development and progression of atherosclerosis and increased cardiovascular events in CKD. Ascorbic acid might be a promising agent in CKD for improving outcome by decreasing oxidative stress and ADMA levels.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.